Worsening of Seizures After Asparagine Supplementation in a Child with Asparagine Synthetase Deficiency
- PMID: 27268761
- DOI: 10.1016/j.pediatrneurol.2016.01.024
Worsening of Seizures After Asparagine Supplementation in a Child with Asparagine Synthetase Deficiency
Abstract
Objective: Asparagine synthetase deficiency is an autosomal recessive neurometabolic disorder characterized clinically by severe congenital microcephaly, global developmental delay, intractable epilepsy, and motor impairment in the form of spastic quadriparesis. Diagnosis is confirmed by findings of low cerebral spinal fluid or plasma asparagine in addition to a mutation of the subsequently in ASNS gene. There is no documented trial of asparagine as a treatment for this disorder.
Patient description: We present a child with asparagine synthetase deficiency whose mental status improved slightly from a vegetative state to a minimally conscious state after starting asparagine supplementation. He subsequently became irritable, developed sleep disturbance, and experienced worsening seizures, requiring discontinuation of the asparagine supplements.
Conclusions: Asparagine supplementation may be not effective in controlling the seizures in asparagine synthetase deficiency, and it is likely to make them worse.
Keywords: ASD; asparagine; asparagine synthetase deficiency; inborn errors of metabolism; l-asparagine; neurometabolic.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Asparagine Synthetase deficiency-report of a novel mutation and review of literature.Metab Brain Dis. 2017 Dec;32(6):1889-1900. doi: 10.1007/s11011-017-0073-6. Epub 2017 Aug 3. Metab Brain Dis. 2017. PMID: 28776279 Review.
-
Characterization of a novel variant in siblings with Asparagine Synthetase Deficiency.Mol Genet Metab. 2018 Mar;123(3):317-325. doi: 10.1016/j.ymgme.2017.12.433. Epub 2017 Dec 20. Mol Genet Metab. 2018. PMID: 29279279 Free PMC article.
-
Epileptic encephalopathy with microcephaly in a patient with asparagine synthetase deficiency: a video-EEG report.Epileptic Disord. 2019 Oct 1;21(5):466-470. doi: 10.1684/epd.2019.1100. Epileptic Disord. 2019. PMID: 31617495
-
Ketogenic diet-responsive drug-resistant epilepsy in a case of asparagine synthetase deficiency with a novel compound heterozygous missense variant.Clin Neurol Neurosurg. 2023 Jul;230:107772. doi: 10.1016/j.clineuro.2023.107772. Epub 2023 May 8. Clin Neurol Neurosurg. 2023. PMID: 37167844
-
Asparagine synthetase: Function, structure, and role in disease.J Biol Chem. 2017 Dec 8;292(49):19952-19958. doi: 10.1074/jbc.R117.819060. Epub 2017 Oct 30. J Biol Chem. 2017. PMID: 29084849 Free PMC article. Review.
Cited by
-
Asparagine synthetase deficiency: A novel case with an unusual molecular mechanism.Mol Genet Metab Rep. 2019 Nov 1;21:100509. doi: 10.1016/j.ymgmr.2019.100509. eCollection 2019 Dec. Mol Genet Metab Rep. 2019. PMID: 31720226 Free PMC article.
-
Clinical whole exome sequencing from dried blood spot identifies novel genetic defect underlying asparagine synthetase deficiency.Clin Case Rep. 2017 Dec 15;6(1):200-205. doi: 10.1002/ccr3.1284. eCollection 2018 Jan. Clin Case Rep. 2017. PMID: 29375865 Free PMC article.
-
Severe Microcephaly and Metabolic Epilepsy due to Asparagine Synthetase Deficiency.Ann Indian Acad Neurol. 2023 Jul-Aug;26(4):570-572. doi: 10.4103/aian.aian_414_23. Epub 2023 Aug 25. Ann Indian Acad Neurol. 2023. PMID: 37970270 Free PMC article. No abstract available.
-
Amino acid metabolism in health and disease.Signal Transduct Target Ther. 2023 Sep 13;8(1):345. doi: 10.1038/s41392-023-01569-3. Signal Transduct Target Ther. 2023. PMID: 37699892 Free PMC article. Review.
-
Clinical outcomes of two patients with a novel pathogenic variant in ASNS: response to asparagine supplementation and review of the literature.Hum Genome Var. 2019 May 22;6:24. doi: 10.1038/s41439-019-0055-9. eCollection 2019. Hum Genome Var. 2019. PMID: 31123592 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
